An NCI-designated Comprehensive Cancer Center

Physician News

City of Hope is the leading cancer hospital in California and the West, according to U.S. News & World Report’s 2019 Best Hospitals: Specialty Ranking. U.S. News also singled out our institution as “high-performing” in lung and colon cancer surgery and rated us fourth in the nation in patient experience.
Covid 19 Coronavirus | City of Hope
COVID-19 and Cancer:
New Protocols and Research Efforts
April 3, 2020 | by City of Hope
As many oncology patients have a compromised immune system, either as a result of the disease or its treatment, they are at an increased risk of infection, including with SARS-CoV-2, the virus that causes COVID-19. As an institution specialized in cancer care, we are on a mission to provide the best possible cancer therapy and protect patients from any infections they may acquire while treating their cancer.
Scorpion Venom for Brain Cancer 300X300
The First to Engineer CAR T Cell Therapy Using a Peptide Component of Scorpion Venom to Target Glioblastoma
March 17, 2020 | by City of Hope
City of Hope scientists have developed and tested the first chimeric antigen receptor (CAR) T cell therapy using chlorotoxin (CLTX), a component of scorpion venom, to direct T cells to target brain tumor cells, according to a preclinical study published today in Science Translational Medicine. The institution has also opened the first in-human clinical trial to use the therapy.
Research Highlights
Breakthroughs - Dr. Trisal and patient - 256x256
City of Hope Receives Two Press Ganey Awards for Exceptional Patient Care
February 14, 2020 | by City of Hope
City of Hope has recently received two national awards for excellence in inpatient care from Press Ganey — the 2019 Guardian of Excellence Award and the 2019 Pinnacle of Excellence Award. The Guardian of Excellence Award recognizes top-performing health care organizations that have consistently achieved the 95th percentile or above for inpatient satisfaction. The Pinnacle of Excellence Award recognizes institutions that maintain consistently high levels of excellence across three years in patient experience.
Thought Leaders
Breakthroughs - Stephen Forman 256x256
City of Hope's BMT survival rates exceed expectations for 15 consecutive years
February 14, 2020 | by City of Hope
City of Hope’s bone marrow transplantation program has achieved a higher-than-expected survival rate based on a 2019 analysis by the Center for International Blood and Marrow Transplant Research.
Hematologic Malignancies | Treatments | Clinical Trials
breakthroughs - t cells
New Immunotherapy Research Presented at ASH Annual Meeting 2019
December 30, 2019 | by City of Hope
Novel research findings on promising therapeutic approaches in lymphoma, myeloma and leukemia were presented by several City of Hope investigators during the ASH annual meeting in Orlando.
Clinical Trials
Breast Cancer Cell 500X500
Moving toward the next
level in breast cancer CAR T cell therapy
October 31, 2019 | by City of Hope
City of Hope is accelerating the development of treatment options for patients with breast cancer who have challenging tumors and poor prognosis with a phase 1 clinical trial that is enrolling patients with refractory HER2-positive breast cancer with brain metastases to test the safety and effectiveness of CAR T cell therapy.
Clinical Trials